Korean J Dermatol.  2023 Jul;61(6):331-341.

Adverse Drug Reactions to Dapsone: A Retrospective Study during the Last 15 Years

Affiliations
  • 1Department of Dermatology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea

Abstract

Background
Dapsone has been used for a long time to treat skin diseases. Although various drug-related side effects and adverse reactions to dapsone have been reported, most studies have addressed only one or two specific reactions to dapsone.
Objective
This study aimed to investigate the overall adverse reactions to dapsone in Koreans and their relationship with patient demographics.
Methods
A retrospective analysis was conducted by reviewing the electronic medical records from 2005 to 2020. The association between adverse drug reactions and dapsone use was assessed using the Naranjo scale. Correlations between variables and adverse reactions were analyzed using univariate and logistic regression analyses.
Results
The overall incidence of adverse drug reactions to dapsone was 7.7% (41 of 533 patients). The incidence was significantly higher in female than in male, and predictable adverse reactions were significantly higher (6.8%, 36 of 533 patients) than in unpredictable cases (0.9%, 5 of 533 patients). The most common adverse event was methemoglobinemia/anemia (3.0%, 16 of 533 patients), and the least common was hypersensitivity syndrome, which occurred in only one case (0.2%, 1 of 533 patients). With the exception of hypersensitivity syndrome, which is a severe drug-related side effects and adverse reactions, most patients recovered after drug discontinuation.
Conclusion
Dapsone can be used relatively safely for various chronic diseases if medical personnel are aware of its adverse reactions.

Keyword

Dapsone; Drug hypersensitivity syndrome; Drug-related side effects and adverse reactions; Female; Methemoglobinemia
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr